Treatment of Leukocytospermia in Male Infertility: A Systematic Review
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIE
- 저널
- WORLD JOURNAL OF MENS HEALTH34(3) · pp.165 · 2016
- 피인용
- Web of Science 45KCI 4
- ISSN
- 2287-4208
저자
- 정재흥제1저자연세대학교
- 김명하연세대학교 원주의학도서관
- 김지예연세대학교
- 백순구연세대학교
- 고상백연세대학교
- 박현준부산대학교
- 서주태교신저자단국대학교
초록
Male factors account for 20% to 50% of infertility cases, and infection in the genitourinary tract may play a contributing role in up to 15% of male infertility. Leukocytospermia is a well-known indicator of infection or inflammation in the male sex glands and the urogenital tract. Although great deal of effort has been expended to elucidate definite management strategies in infertile men with leukocytospermia, the gold standard of treatment remains unclear. Until recently, broad spectrum antibiotics and antioxidants have been used in the treatment of leukocytospermia for male infertility to eliminate infection and reduce reactive oxygen free radicals produced inside cellular mitochondria as a result of inflammation. The present review reveals that antibiotics might improve sperm parameters, the rate of resolution of leukocytospermia, the bacteriologic cure rate, and even the pregnancy rate, although some reports conflict. Antioxidants might also have clinical benefits for sperm function as shown by in vitro studies. However, the data are insufficient to conclude whether antibiotics and antioxidants for the treatment of infertile men with leukocytospermia are effective or not. Better designed investigations into leukocytospermia are needed.
키워드
식별자
- WoS UID
- 000393311600002
- KCI
- ART002173725



로그인
연구물 목록으로